The DOI matches its OpenAlex record; 50 of the 50 references it cites were found in a registry or an index.
Corticotropin-Releasing Hormone Induces Skin Mast Cell Degranulation and Increased Vascular Permeability, A Possible Explanation for Its Proinflammatory Effects
Open accessAbstract
Mast cells are involved in atopic disorders, often exacerbated by stress, and are located perivascularly close to sympathetic and sensory nerve endings. Mast cells are activated by electrical nerve stimulation and millimolar concentrations of neuropeptides, such as substance P (SP). Moreover, acute psychological stress induces CRH-dependent mast cell degranulation. Intradermal administration of rat/human CRH (0.1-10 microM) in the rat induced mast cell degranulation and increased capillary permeability in a dose-dependent fashion. The effect of CRH on Evans blue extravasation was stronger than equimolar concentrations of the mast cell secretagogue compound 48/80 or SP. The free acid analog of CRH, which does not interact with its receptors (CRHR), had no biological activity. Moreover, systemic administration of antalarmin, a nonpeptide CRHR1 antagonist, prevented vascular permeability only by CRH and not by compound 48/80 or SP. CRHR1 was also identified in cultured leukemic human mast cells using RT-PCR. The stimulatory effect of CRH, like that of compound 48/80 on skin vasodilation, could not be elicited in the mast cell deficient W/Wv mice but was present in their +/+ controls, as well as in C57BL/6J mice; histamine could still induce vasodilation in the W/Wv mice. Treatment of rats neonatally with capsaicin had no effect on either Evans blue extravasation or mast cell degranulation, indicating that the effect of exogenous CRH in the skin was not secondary to or dependent on the release of neuropeptides from sensory nerve endings. The effect of CRH on Evans blue extravasation and mast cell degranulation was inhibited by the mast cell stabilizer disodium cromoglycate (cromolyn), but not by the antisecretory molecule somatostatin. To investigate which vasodilatory molecules might be involved in the increase in vascular permeability, the CRH injection site was pretreated with the H1-receptor antagonist diphenhydramine, which largely inhibited the CRH effect, suggesting that histamine was involved in the CRH-induced vasodilation. The possibility that nitric oxide might also be involved was tested using pretreatment with a nitric oxide synthase inhibitor that, however, increased the effect of CRH. These findings indicate that CRH activates skin mast cells at least via a CRHR1-dependent mechanism leading to vasodilation and increased vascular permeability. The present results have implications for the pathophysiology and possible therapy of skin disorders, such as atopic dermatitis, eczema, psoriasis, and urticaria, which are exacerbated or precipitated by stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Self-citationVaughan, J., Donaldson, C., Bittencourt, J., Perrin, M. H., Lewis, K., Sutton, S., Chan, R., Turnbull, A. V., Lovejoy, D., Rivier, C., et al. (1995) · Nature · doi:10.1038/378287a0 · Cited by 1,479
New Concepts about the Mast Cell
Flier, J. S., Underhill, L. H., & Galli, S. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301283280408 · Cited by 990
Expression cloning of a human corticotropin-releasing-factor receptor.
Chen, R., Lewis, K. A., Perrin, M. H., & Vale, W. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8967 · Cited by 927
Inflammation, immunoregulation, and inducible nitric oxide synthase
Nussler, A. K., & Billiar, T. R. (1993) · Journal of Leukocyte Biology · doi:10.1002/jlb.54.2.171 · Cited by 860
Walsh, L. J., Trinchieri, G., Waldorf, H. A., Whitaker, D., & Murphy, G. F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4220 · Cited by 622
Autocrine or Paracrine Inflammatory Actions of Corticotropin-Releasing Hormone in Vivo
Karalis, K., Sano, H., Redwine, J., Listwak, S., Wilder, R. L., & Chrousos, G. P. (1991) · Science · doi:10.1126/science.1925600 · Cited by 482
Self-citationLovenberg, T. W., Chalmers, D. T., Liu, C., & Souza, E. B. D. (1995) · Endocrinology · doi:10.1210/en.136.9.4139 · Cited by 458
Markowitz, S., Saito, K., & Moskowitz, M. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-12-04129.1987 · Cited by 440
Schulz, D. W., Mansbach, R. S., Sprouse, J., Braselton, J. P., Collins, J., Corman, M., Dunaiskis, A., Faraci, S., Schmidt, A. W., Seeger, T., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10477 · Cited by 377
Webster, E. L. (1996) · Endocrinology · doi:10.1210/en.137.12.5747 · Cited by 312
Self-citationModulation of immunity and hypersensitivity by sensory neuropeptides.
Payan, D. G., Levine, J. D., & Goetzl, E. J. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.4.1601 · Cited by 282
Dimtriadou, V., Buzzi, M. G., Moskowitz, M. A., & Theoharides, T. C. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90253-k · Cited by 275
Self-citationIncreased number of substance P positive nerve fibres in interstitial cystitis
Pang, X., Marchand, J., Sant, G. R., Kream, R. M., Theoharides, T. C., & J. (1995) · British Journal of Urology · doi:10.1111/j.1464-410x.1995.tb07384.x · Cited by 249
Self-citationTheoharides, T. C., Sieghart, W., Greengard, P., & Douglas, W. W. (1980) · Science · doi:10.1126/science.6153130 · Cited by 245
Self-citationCrofford, L. J., Sano, H., Karalis, K., Friedman, T. C., Epps, H. R., Remmers, E. F., Mathern, P., Chrousos, G. P., & Wilder, R. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1587 · Cited by 216
Self-citationCharacterization of neuropeptide‐induced histamine release from human dispersed skin mast cells
Lowman, M. A., Benyon, R. C., & Church, M. K. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb16555.x · Cited by 215
Theoharides, T. C., Spanos, C., Pang, X., Alferes, L., Ligris, K., Letourneau, R., Rozniecki, J. J., Webster, E., & Chrousos, G. P. (1995) · Endocrinology · doi:10.1210/endo.136.12.7588332 · Cited by 214
Self-citationCrofford, L. J., Sano, H., Karalis, K., Webster, E. L., Goldmuntz, E. A., Chrousos, G. P., & Wilder, R. L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116150 · Cited by 205
Self-citationKaralis, K., Muglia, L. J., Bae, D., Hilderbrand, H., & Majzoub, J. A. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00178-6 · Cited by 203
Substance P induces granulocyte infiltration through degranulation of mast cells.
Matsuda, H., Kawakita, K., Kiso, Y., Nakano, T., & Kitamura, Y. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.3.927 · Cited by 194
Yano, H., Wershil, B. K., Arizono, N., & Galli, S. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114295 · Cited by 189
Requirement for vasoactive amines for production of delayed-type hypersensitvity skin reactions.
Gershon, R. K., Askenase, P. W., & Gershon, M. D. (1975) · The Journal of Experimental Medicine · doi:10.1084/jem.142.3.732 · Cited by 182
The mast cell: a neuroimmunoendocrine master player.
Theoharides, T. C. (1996) · PubMed · Cited by 181
Self-citationKaranth, S., Lyson, K., & McCann, S. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3383 · Cited by 176
Distribution and Characterization of Immunoreactive Corticotropin-Releasing Factor in Human Tissues*
SUDA, T., TOMORI, N., TOZAWA, F., MOURI, T., DEMURA, H., & SHIZUME, K. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-5-861 · Cited by 171
Slominski, A., Ermak, G., Hwang, J., Chakraborty, A., Mazurkiewicz, J. E., & Mihm, M. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01090-2 · Cited by 160
VAMVAKOPOULOS, N. C., & CHROUSOS, G. P. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-4-409 · Cited by 159
Self-citationClifton, V. L., Read, M. A., Leitch, I. M., Giles, W. B., Boura, A. L. A., Robinson, P. J., & Smith, R. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.10.7559870 · Cited by 150
Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis.
Kawahito, Y., Sano, H., Mukai, S., Asai, K., Kimura, S., Yamamura, Y., Kato, H., Chrousos, G. P., Wilder, R. L., & Kondo, M. (1995) · Gut · doi:10.1136/gut.37.4.544 · Cited by 148
Self-citationAlexander‐Miller, M. A., Burke, K. L., Koszinowski, U. H., Hansen, T. H., & Connolly, J. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.1.1 · Cited by 148
Skofitsch, G., Zamir, N., Helke, C. J., Savitt, J. M., & Jacobowitz, D. M. (1985) · Peptides · doi:10.1016/0196-9781(85)90057-9 · Cited by 135
Neurogenic inflammation, vascular permeability, and mast cells.
Kowalski, M. L., & Kaliner, M. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.11.3905 · Cited by 133
Immunocytochemical localization of corticotropin releasing factor (CRF) in the rat spinal cord
Merchenthaler, I. J., Hynes, M., Vígh, S., Shally, A. V., & Petrusz, P. (1983) · Brain Research · doi:10.1016/0006-8993(83)91001-6 · Cited by 130
Irwin, M. R., Hauger, R. L., Jones, L., Provencio, M. G. A., & Britton, K. T. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12679-7 · Cited by 124
Singh, V. K., & Leu, S.-J. C. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90025-5 · Cited by 123
Mast Cells: The Neuroimmune Connection
Williams, R. M., Bienenstock, J., & Stead, R. H. (2015) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000424590 · Cited by 112
Turnbull, A. V., & Rivier, C. (1996) · Endocrinology · doi:10.1210/endo.137.2.8593789 · Cited by 95 · cited 1×
“In the hypothalamus, NO has been reported to both stimulate (53) and inhibit (54) CRH secretion.”
BackgroundDefinitive characterization of rat hypothalamic mast cells
Pang, X., Létourneau, R., Rózniecki, J., Wang, L., & Theoharides, T. C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00606-0 · Cited by 82
Self-citationSOMATOSTATIN INDUCES HISTAMINE SECRETION FROM RAT PERITONEAL MAST CELLS1
Theoharides, T. C., & Douglas, W. W. (1978) · Endocrinology · doi:10.1210/endo-102-5-1637 · Cited by 70
Self-citationTaylor, A. M., Galli, S. J., & Coleman, J. W. (1995) · PubMed · Cited by 68
Purification of Tryptase From a Human Mast Cell Line
Butterfield, J. H., Weiler, D. A., Hunt, L. W., Wynn, S. R., & Roche, P. C. (1990) · Journal of Leukocyte Biology · doi:10.1002/jlb.47.5.409 · Cited by 65
Mannaioni, P. F., Masini, E., Pistelli, A., Salvemini, D., & Vane, J. R. (1991) · PubMed · Cited by 58
Mastorakos, G. P., Bouzas, E. A., Silver, P. B., Sartani, G., Friedman, T. C., Chan, C., Caspi, R. R., & Chrousos, G. P. (1995) · Endocrinology · doi:10.1210/endo.136.10.7664685 · Cited by 57
Self-citationHistamine Releasing Factors and Cytokine-Dependent Activation of Basophils and Mast Cells
Kaplan, A. P., Reddigari, S. R., Baeza, M., & Kuna, P. (1991) · Advances in immunology · doi:10.1016/s0065-2776(08)60826-3 · Cited by 50
Presence of immunoreactive corticotropin releasing hormone in thyroid lesions.
Scopa, C. D., Mastorakos, G. P., Friedman, T. C., Melachrinou, M., Merino, M. J., & Chrousos, G. P. (1994) · PubMed Central · Cited by 50
Self-citationQiu, B., Pothoulakis, C., Castagliuolo, I., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8690206 · Cited by 48
Keller, J., Dimlich, R., Zuccarello, M., Lanker, L., Strauss, T. A., & Fritts, M. (1991) · Cephalalgia · doi:10.1046/j.1468-2982.1991.1105215.x · Cited by 38
Roe, C. M., Leitch, I. M., Boura, A. L. A., & Smith, R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636301 · Cited by 31
Dermatitis Characterized by Mastocytosis at Immunization Sites in Mast-Cell-Deficient W/W v Mice
Theoharides, T. C., El-Mansoury, M., Létourneau, R., Boucher, W. S., & Rózniecki, J. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000236583 · Cited by 18
Self-citation
Cited by
Middleton, E., Kandaswami, C., & Theoharides, T. C. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01472-8 · Cited by 4,882
Self-citationStress and disorders of the stress system
Chrousos, G. P. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.106 · Cited by 3,215
“Peripheral secretion of 'authentic' CRH (originally described as 'immune' CRH because of its inflammatory actions) by postganglionic sympathetic neurons and norepinephrine-activated release of IL-6 by peripheral immune cells and other cells, respectively, lead to degranulation of mast cells (that is, the release of in…”
BackgroundSelf-citationElenkov, I. J., Wilder, R. L., Chrousos, G. P., & Vizi, E. S. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01470-4 · Cited by 2,252
Self-citationThe induction of pain: an integrative review
Millan, M. J. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00048-3 · Cited by 1,774
Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity
ELENKOV, I. J., & CHROUSOS, G. P. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04229.x · Cited by 983
Self-citation
Metadata
- Authors
- Theoharides, T. C., Singh, L. K., Boucher, W. S., Pang, X., Létourneau, R., Webster, E., & Chrousos, G. P.
- Venue
- Endocrinology
- Publisher
- Oxford University Press
- Published
- 1998-01-01
- Volume
- 139
- Issue
- 1
- Pages
- 403-413
- ISSN
- 0013-7227 (ISSN-L)
- OpenAlex
- W2037261229
- Cited by
- 447
- References
- 50
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.